Sign in
4

Changes in Ownership

RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001104659-24-060559

Chief Technical Officer sold 3,984 shares at an average $38.47 ($153,259)

  • Chief Technical Officer acquired 3,984 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Shulman Joseph Chief Technical Officer 2024-05-09 Option exercise 10b5-1 +3,984 $6.80 $27,091 4,014 D
Shulman Joseph Chief Technical Officer 2024-05-09 Sale 10b5-1 −3,484 $38.38 $133,708 530 D
Shulman Joseph Chief Technical Officer 2024-05-09 Sale 10b5-1 −500 $39.10 $19,551 30 D
Derivatives
Shulman Joseph Chief Technical Officer 2024-05-09 Option exercise · Stock Option (right to buy) 10b5-1 −3,984 31,875 D
Open-market sales · 3,984 sh · avg $38.47 · $153,259
Loading xslF345X05/tm2414300-1_4seq1.xml…